Literature DB >> 16697954

The challenges of gene expression microarrays for the study of human cancer.

Anna V Tinker1, Alex Boussioutas, David D L Bowtell.   

Abstract

Large-scale genomic studies promise to advance our understanding of the biology of human cancers and to improve their diagnosis, prognostication, and treatment. The analysis and interpretation of genomics studies have faced challenges. The retrospective and observational design of many studies has rendered them susceptible to confounding and bias. Technological variations and advances have impacted on reproducibility. Statistical hurdles in relating a large number of variables to a small number of observations have added further constraints. This review considers the promise and challenge associated with the large-scale clinically oriented genomic analysis of human cancer and attempts to emphasize potential solutions.

Entities:  

Mesh:

Year:  2006        PMID: 16697954     DOI: 10.1016/j.ccr.2006.05.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  34 in total

Review 1.  Technical variables in high-throughput miRNA expression profiling: much work remains to be done.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard R Wilfred; Guiliang Tang
Journal:  Biochim Biophys Acta       Date:  2008-04-07

Review 2.  Clinical uses of microarrays in cancer research.

Authors:  Carl Virtanen; James Woodgett
Journal:  Methods Mol Med       Date:  2008

Review 3.  Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains.

Authors:  Halliday A Idikio
Journal:  Int J Clin Exp Pathol       Date:  2009-11-25

4.  [Bioinformatics analysis of COL1A1 regulated by miR-129-5p as a potential therapeutic target for gastric cancer].

Authors:  Wanxia Yang; Yunyan Pan; Peiwen Guan; Xue Li; Chongge You
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

5.  A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients.

Authors:  Erica Lorena Kreimann; Magdalena Ratajska; Alina Kuzniacka; Brenda Demacopulo; Maciej Stukan; Janusz Limon
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

Review 6.  Genes involved in neuroendocrine tumor biology.

Authors:  Eva Hofsli
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

7.  Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

Authors:  Joëlle Vermeulen; Katleen De Preter; Arlene Naranjo; Liesbeth Vercruysse; Nadine Van Roy; Jan Hellemans; Katrien Swerts; Sophie Bravo; Paola Scaruffi; Gian Paolo Tonini; Bruno De Bernardi; Rosa Noguera; Marta Piqueras; Adela Cañete; Victoria Castel; Isabelle Janoueix-Lerosey; Olivier Delattre; Gudrun Schleiermacher; Jean Michon; Valérie Combaret; Matthias Fischer; André Oberthuer; Peter F Ambros; Klaus Beiske; Jean Bénard; Bárbara Marques; Hervé Rubie; Janice Kohler; Ulrike Pötschger; Ruth Ladenstein; Michael D Hogarty; Patrick McGrady; Wendy B London; Geneviève Laureys; Frank Speleman; Jo Vandesompele
Journal:  Lancet Oncol       Date:  2009-06-08       Impact factor: 41.316

Review 8.  Towards a multiscale model of colorectal cancer.

Authors:  Ingeborg M M van Leeuwen; Carina M Edwards; Mohammad Ilyas; Helen M Byrne
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

Review 9.  A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.

Authors:  Bas J Wouters; Bob Löwenberg; Ruud Delwel
Journal:  Blood       Date:  2008-08-14       Impact factor: 22.113

10.  Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.

Authors:  Dohun Pyeon; Michael A Newton; Paul F Lambert; Johan A den Boon; Srikumar Sengupta; Carmen J Marsit; Craig D Woodworth; Joseph P Connor; Thomas H Haugen; Elaine M Smith; Karl T Kelsey; Lubomir P Turek; Paul Ahlquist
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.